S&P sets new record with coronavirus stimulus, vaccine in focus
U.S. equity markets opened in record territory as traders weighed a setback in COVID-19 relief talks and the pending approval of a vaccine.
Wednesday, December 9, 2020
S&P sets new record with coronavirus stimulus, vaccine in focus
S&P sets new record with coronavirus stimulus, vaccine in focus
U.S. equity markets opened in record territory as traders weighed a setback in COVID-19 relief talks and the pending approval of a vaccine.
Related Posts:
Better Buy: Toyota vs. Fiat Chrysler Automobiles- Unclaimed $1.5B jackpot mystery: Winner died? Ticket lost?
- This High-Yield Stock Slashed Its Dividend in Half. It's an Even Better Buy Now.
- Bayer faces second trial over alleged Roundup cancer risk
- Huawei breaks price ceiling with $2,600 folding 5G smartphone
0 comments:
Post a Comment